BRAF as a melanoma susceptibility candidate gene?

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3061-3065

  Laud, Karine ^a   Kannengiesser, Caroline ^a   Avril, Marie Francoise ^a   Chompret, Agnès ^e   Stoppa Lyonnet, Dominique ^b   Desjardins, Laurence ^b   Eychene, Alain ^c   Demenais, Florence ^d   Andry Benzaquen, P ^e   Baccard, M ^e   Bachollet, B ^e   Basset Seguin, N ^e   Baspeyras, M ^e   Berthet, P ^e   Bonnetblanc, J M ^e   Blanchet, P ^e   Boitier, F ^e   Bonadona, V ^e   Caux, F ^e   Cesarini, J P ^e   Chevrant Breton, J ^e   Couillet, D ^e   Courouge Dorcier, A M ^e   Demange, L ^e   Levy, C ^e   Dereure, O ^e   D'Incan, M ^e   Dore, M ^e   Esteve, E ^e   Frenay, M ^e   Gaillard, V ^e   Gorin, I ^e   Grange, F ^e   Guillot, B ^e   Joly, P ^e   Laroche, L ^e   Lasset, C ^e   Leroux, D ^e   Limacher, J M ^e   Longy, M ^e   Lumbroso, L ^e   Michel, J L ^e   Negrier, S ^e   Ollivaud, L ^e   Ortoli, J C ^e   Robin, P ^e   Sassolas, B ^e   Triller, R ^e   Truchetet, F ^e   Vabres, P ^e   Verne, L ^e   Lenoir, Gilbert M ^a   Bressac de Paillerets, Brigitte ^a   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c CNRS   (France)

^d INSERM   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILIAL CANCER; GENE MUTATION; GERM LINE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UVEA MELANOMA;

CHROMOSOME SEGREGATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FAMILY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; INTRONS; MELANOMA; NEOPLASM PROTEINS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, NERVE TISSUE; NEOPLASTIC SYNDROMES, HEREDITARY; NEVUS, PIGMENTED; POINT MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; SKIN NEOPLASMS;

EID: 0038408488     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bressac-de-Paillerets, B., Avril, M. F., Chompret, A., and Demenais, F. Genetic and enviromnental factors in cutaneous malignant melanoma. Biochimie, 84: 67-74, 2002.
2. Hussussian, C. J., Struewing, J. P., Goldstein, A. M. Higgins, P. A. T., Ally, D. S., Steahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
3. Kamb, A., Shaltuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J. F., Andergon, D. E., Bergman, W., Frants, R., Goldar, D. E., Green, A. MacLennan, R., Martin, N. G. Meyer, L. J., Youl, P., Zone, J. J., Skolnick, M. H., and Cannon-Albright, L. A. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet., 8: 22-26, 1994.
4. INK4a binding domain of CDK4 in familial melanoma. Nat. Genet., 12: 97-99, 1996.
5. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of including cell cycle arrest. Cell. 83: 993-1000, 1995.
6. Classon, M., and Harlow, E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer. 2: 910-917, 2002.
7. Zhang, Y., Xiong, Y., and Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92: 725-734, 1998.
8. Bishop, D. T., Demenais, F., Goldstein, A. M., Bergman, W., Bishop, S. N., Paillerets, B. B., Chompret, A., Ghiorzo, P., Gruis, N., Hansson, J., Harland, M., Hayward, N., Holland, E. A., Mann, G. J., Mantelli, M., Nancarrow, D., Platz, A., and Tucker, M. A. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl. Cancer Inst., 94: 894-903, 2002.
9. Soufir, N., Avril, M. F., Chompret, A., Demenais, F., Bombled, J., Spatz, A., Stoppa-Lyonnet, D., the French Familial Melanoma Study Group, Bénard, J. and Bressac-de Paillerets, B. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum. Mol. Genet., 7: 209-216, 1998.
10. Randerson-Moor, J. A., Harland, M., Williams, S., Cuthbert-Heavens, D., Sheridan, E., Aveyard, J., Sibley, K., Whitaker, L., Knowles, M., Newton, B. J., and Bishop, D. T. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum. Mol. Genet., 10: 55-62, 2001.
11. Hewitt, C., Lee, W. C., Evans, G., Howell, A., Elles, R. G., Jordan, R., Sloan, P., Read, A. P., and Thakker, N. Germline mutation of ARF in a melanoma kindred. Hum. Mol. Genet., 11: 1273-1279, 2002.
12. Monzon, J., Liu, L., Brill, H., Goldstein, A. M., Tucker, M. A., From, L., McLaughlin, J., Hogg, D., and Lassam, N. J. CDKN2A mutations in multiple primary melanomas. N. Engl. J. Med., 338: 879-887, 1998.
13. Auroy, S., Avril, M. F., Chompret, A., Pham, D., Goldstein, A. M., Bianchi-Scarra, G., Frebourg, T., Joly, P., Spatz, A., Rubino, C., Demenais, F., and Bressac-de Paillerets, B. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect. Genes Chromosomes Cancer, 32: 195-202, 2001.
14. Whiteman, D. C., Milligan, A., Welch, J., Green, A. C., and Hayward, N. K. Germline CDKN2A mutations in childhood melanoma. J. Natl. Cancer Inst, 89: 1460-1460, 1997.
15. Soufir, N., Bressac-de Paillerets, B., Desjardins, L. Levy, C., Bombled, J., Gorin, I., Schlienger, P., and Stoppa-Lyonnet, D. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A. P14ARF or cdk4 genes. Br. J. Cancer, 82: 818-822, 2000.
16. Peyssonnaux, C., and Eychene, A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell, 93: 53-62, 2001.
17. Busca, R., Abbe, P., Mantoux, F., Aberdam, E., Peyssonnaux, C., Eychene, A., Ortonne, J. P., and Ballotti, R. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J., 19: 2900-2910, 2000.
18. Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., Horner, J. W., Cordon Cardo, C. Yancopoulos, G. D., and DePinho, R. A. Essential role for oncogenic Ras in tumour maintenance. Nature (Lond.), 400: 468-472, 1999.
19. Papp, T., Pernsel, H., Zimmermann, R., Bastrop, R., Weiss, D. G., and Schiffmann, D. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MCIR genes in human congenital melanocytic naevi. J. Med. Genet., 36: 610-614, 1999.
20. Davies, H., Bignell G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Gamett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Woosler, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature (Lond.), 417: 949-954, 2002.
21. Brose, M. S., Volpe, P., Feldman, M., Kumar, M., Rishi, I., Gerrero, R., Einhorn, E., Herlyn, M., Minna, J., Nicholson, A., Roth, J. A., Albelda, S. M., Davies, H., Cox, C., Brignell, G., Stephens, P., Futreal, P. A., Wooster, R., Stratton, M. R., and Weber, B. L. BRAF and RAS Mutations in human lung cancer and melanoma. Cancer Res., 62: 6997-7000, 2002.
22. Pollock, P. M., Harper, U. L., Hansen, K. S., Yudi, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetler, G., Wagner, U., Kakareka, J., Salem, G., Pohida, T., Heenan, P., Duray, P., Kallioniemi, O., Hayward, N. K., Trent, J. M., and Meltzer, P. S. High frequency of BRAF mutations in nevi. Nat. Genet., 2002.
23. Barnier, J. V. Papin, C., Eychene, A., Lecoq, O., and Calothy, G. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J. Biol. Chem., 270: 23381-23389, 1995.
24. Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W. 2., and DePinho, R. A. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev., 11: 2822-2834, 1997.
25. Dhillon, A. S., Pollock, C., Steen, H., Shaw, P. E., Mischak, H., and Kolch, W. Cyclic AMP dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol. Cell Biol., 22: 3237-3246, 2002.